Detalhe da pesquisa
1.
Siltuximab administration results in spurious IL-6 elevation in peripheral blood.
Am J Hematol
; 99(1): E15-E18, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867418
2.
Ongoing symptoms following complete surgical excision in unicentric Castleman disease.
Am J Hematol
; 98(11): E334-E337, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635628
3.
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes.
Blood Adv
; 7(21): 6652-6664, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656441